Cargando…
Novel C15 Triene Triazole, D-A Derivatives Anti-HepG2, and as HDAC2 Inhibitors: A Synergy Study
A series of novel C15 urushiol derivatives were designed by introducing a pechmann structure and F-, Cl-, and Br-nitro substituents with different electronic properties into its alkyl side chain, as well as a triazolyl functional group in its aromatic oxide. Their chemical structures were determined...
Autores principales: | Qi, Zhiwen, Wang, Chengzhang, Jiang, Jianxin, Wu, Caie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214004/ https://www.ncbi.nlm.nih.gov/pubmed/30332739 http://dx.doi.org/10.3390/ijms19103184 |
Ejemplares similares
-
Synthesis and Evaluation of C15 Triene Urushiol Derivatives as Potential Anticancer Agents and HDAC2 Inhibitor
por: Qi, Zhiwen, et al.
Publicado: (2018) -
Anticancer Effect of Rh2, a Histone Deacetylase Inhibitor, in HepG2 Cells and HepG2 Cell-Derived Xenograft Tumors Occurs via the Inhibition of HDACs and Activation of the MAPK Signaling Pathway
por: Qiang, Shi Qing, et al.
Publicado: (2021) -
HBV Integration-mediated Cell Apoptosis in HepG2.2.15
por: Hu, Xiaoge, et al.
Publicado: (2019) -
TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK–STAT signaling pathway
por: Zhu, X, et al.
Publicado: (2016) -
Melittin Restores PTEN Expression by Down-Regulating HDAC2 in Human Hepatocelluar Carcinoma HepG2 Cells
por: Zhang, Hui, et al.
Publicado: (2014)